آخرین بروزرسانی چهارشنبه 1404/05/15
  1. انتشارات جعفری نوین
  2. لاتین
  3. خون و سرطان - Hematology & Oncology
  4. پرتو درمانی استریوتاکتیک بدن Stereotactic Body Radiation Therapy : Technical Brief Number 6
دارای 1% تخفیف

پرتو درمانی استریوتاکتیک بدن
Stereotactic Body Radiation Therapy : Technical Brief Number 6

کد کتاب 143812
(34 )

Stereotactic Body Radiation Therapy : Technical Brief Number 6

پرتو درمانی استریوتاکتیک بدن

افست = اورجینال
چاپ تمام رنگی

کاغذ 80 گرمی اندونزی
جلد سخت / ته دوخت / سیمی

*بهترین کیفیت افست را از ما بخواهید*

توسعه پرتو درمانی استریوتاکتیک بدن (SBRT) در اوایل دهه 1990 در موسسه کارولینسکا (استکهلم ، سوئد) با محققان اینگمار لاکس و هنریک بلومگرن آغاز شد و از تکنیک ها و روشهای رادیو جراحی استریوتاکتیک (SRS) گرفته شده بود. محققان ژاپنی و آمریکای شمالی در این مدت در دهه 1990 به توسعه این درمان کمک کردند.

تعداد صفحه
206
چاپ
رنگی
زبان
انگلیسی
سال نشر
2013
قطع
رحلی

موجود در انبار (قیمت و موجودی بروز می باشد ، با خیال راحت خرید کنید)

خرید کتاب پرتو درمانی استریوتاکتیک بدن با 1 درصد تخفیف

Stereotactic Body Radiation Therapy : Technical Brief Number 6

پرتو درمانی استریوتاکتیک بدن

The development of stereotactic body radiation therapy (SBRT) began in the early 1990s at the Karolinska Institute (Stockholm, Sweden) with researchers Ingmar Lax and Henric Blomgren and was derived from the techniques and procedures of stereotactic radiosurgery (SRS). Researchers in Japan and North America helped develop this treatment during this same time in the 1990s. The American College of Radiology (ACR) and the American Society for Radiation Oncology (ASTRO) define SBRT as "an external beam radiation therapy method used to very precisely deliver a high dose of radiation to an extracranial target within the body, using either a single dose or a small number of fractions." SBRT combines multiple finely collimated radiation beams and stereotaxy (3D target localization). The multiple radiation beams intersect to deliver an accurate, high dose of radiation to a carefully defined location. There are several terms that have been used interchangeably for SBRT. These terms include "stereotactic radiotherapy," "fractionated stereotactic radiosurgery," "hypofractionated stereotactic radiosurgery," and "staged radiosurgery." Consensus does not exist for the definition of SBRT with respect to a maximum number of radiation fractions, the minimum radiation dose per fraction, or the maximum number and diameter of lesions to be treated. SBRT is characterized by patient immobilization, limiting normal tissue exposure to highdose radiation, preventing or accounting for organ motion (e.g., respiratory motion), the use of stereotaxy, and the subcentimeter accuracy of the delivered dose. The key components of a SBRT procedure are target delineation, treatment planning, and treatment delivery. The treatment team includes a radiation oncologist, medical physicist, radiation therapist, and depending on the body site and indication, a diagnostic radiologist, nurse, anesthetist, and dosimetrist as needed.6 Medical professionals, such as surgeons, may also play a role in the treatment team. Stereotactic radiosurgery is a distinct discipline that utilizes externally generated ionizing radiation in certain cases to inactivate or eradicate (a) defined target (s) in the head or spine without the need to make an incision. The target is defined by high-resolution stereotactic imaging. To assure quality of patient care the procedure involves a multidisciplinary team consisting of a neurosurgeon, radiation oncologist, and medical physicist. Stereotactic radiosurgery (SRS) is typically performed in a single session, using a rigidly attached stereotactic guiding device, other immobilization technology and/or a stereotactic image-guidance system, but can be performed in a limited number of sessions, up to a maximum of five. Technologies that are used to perform SRS include linear accelerators, particle beam accelerators and multisource Cobalt 60 units. In order to enhance precision, various devices may incorporate robotics and real time imaging. The goal of this Technical Brief is to provide a broad overview of the current state of SBRT for solid malignant tumors. This Technical Brief reports on the current technologies available to deliver SBRT; the types and locations of tumors that have been treated with SBRT; the possible advantages and disadvantages of the technology; the extent of diffusion of the technology; and provide information about advances in the technology that are currently in development.

Product details

سایر کتابهای مرتبط

1%
2,096,700 تومان2,075,733 تومان
1%
608,400 تومان602,316 تومان
1%
1,691,400 تومان1,674,486 تومان
1%
608,400 تومان602,316 تومان
1%
کد کتاب : 143833

778,800 تومان771,012 تومان
1%
کد کتاب : 143796

1,472,400 تومان1,457,676 تومان
1%
924,900 تومان915,651 تومان
1%
1,034,300 تومان1,023,957 تومان
1%
4,056,000 تومان4,015,440 تومان
1%
1,801,000 تومان1,782,990 تومان
1%
902,600 تومان893,574 تومان
1%
827,600 تومان819,324 تومان
1%
کد کتاب : 143528

857,900 تومان849,321 تومان
1%
1,119,500 تومان1,108,305 تومان

پرفروش های لاتین/خون و سرطان - Hematology & Oncology

10%
کد کتاب : 103743

انتشارات John Wiley-Sons

1,874,000 تومان1,686,600 تومان
10%
کد کتاب : 104092

انتشارات Springer

709,800 تومان638,820 تومان
10%
کد کتاب : 104107

انتشارات Oxford University Press

3,747,900 تومان3,373,110 تومان
10%
کد کتاب : 104161

انتشارات ELSEVIER

3,244,800 تومان2,920,320 تومان
10%
1,168,200 تومان1,051,380 تومان
10%
کد کتاب : 104248

انتشارات Lippincott Williams

5,070,000 تومان4,563,000 تومان